Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Management of Chronic Kidney Disease Stages 1–3

Slide: 26 of 29

Conclusions: Screening and Monitoring

Based on treatment-related findings of randomized controlled trials and additional indirect data—including high chronic kidney disease (CKD) prevalence, low CKD recognition, and limited CKD monitoring in usual care; uncertain sensitivity of screening and monitoring measures for CKD; and insufficient evidence on CKD screening and monitoring harms—the overall benefits of CKD screening and monitoring are unclear. The likelihood of benefit, if present, appears to be greater in specific subgroups. Younger patients and those without diabetes, hypertension, cardiovascular disease, or obesity are the least likely to benefit from CKD screening.